Nature's Sunshine (NATR) Lays Out a $1B Growth Target Amid Guidance Cuts
On August 6, Nature's Sunshine Products (NASDAQ:NATR) held its second-quarter earnings call, and the numbers told two very different stories at once.
Natures Sunshine Products Inc (NATR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Wynnefield Capital Nelson Obus | 2,473,686 | $53,926,354 | 37.09% | |
| 2. | Prescott Group Capital Management Phil Frohlich | 1,783,097 | $38,871,516 | 3.36% | |
| 3. | Renaissance Technologies Jim Simons | 527,568 | $11,500,982 | -1% | 0.02% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 191,251 | $4,169,272 | +12% | 0% |
| 5. | GLG Partners Noam Gottesman | 126,873 | $2,765,831 | +217% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.69 | 20,000 | $293,800.00 | 1,944,486 | 2026-08-17 | Filing | |
| $16.01 | 10,000 | $160,100.00 | 1,924,486 | 2026-08-10 | Filing | |
| $15.78 | 13,072 | $206,276.16 | 1,914,486 | 2026-08-10 | Filing | |
| $15.80 | 16,928 | $267,462.40 | 1,901,414 | 2026-08-10 | Filing | |
| $15.64 | 876 | $13,700.64 | 1,884,486 | 2026-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.75 | 866 | $17,969.50 | 48,866 | 2026-06-12 | Filing | |
| $20.63 | 1,134 | $23,394.42 | 49,732 | 2026-06-12 | Filing | |
| $19.90 | 11,968 | $238,163.20 | 77,446 | 2026-06-05 | Filing | |
| $20.64 | 9,713 | $200,476.32 | 47,276 | 2026-06-01 | Filing | |
| $21.84 | 12,015 | $262,407.60 | 43,438 | 2026-05-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 989,020 | $21,560,637 | 0% | |
| 2. | 923,626 | $20,134,573 | 0% | |
| 3. | 714,829 | $15,583,272 | 0.01% | |
| 4. | 623,831 | $13,599,516 | 0.24% | |
| 5. | 604,411 | $13,176,160 | 0% |
News See All
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q1 2026 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q1 2026 Earnings Call Transcript May 7, 2026Nature's Sunshine Products, Inc. beats earnings expectations. Reported EPS is $0.3, expectations were $0.205.
10 Best Small-Cap Consumer Staples Stocks to Buy Under $30
In this article, we will explore the 10 Best Small-Cap Consumer Staples Stocks to Buy Under $30. On March 13, Reuters took a close look at where U.S.
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q4 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q4 2025 Earnings Call Transcript March 10, 2026Nature's Sunshine Products, Inc. beats earnings expectations.
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q3 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q3 2025 Earnings Call Transcript November 6, 2025Nature's Sunshine Products, Inc. beats earnings expectations.
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q2 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc.
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q1 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q1 2025 Earnings Call Transcript May 6, 2025Nature's Sunshine Products, Inc. beats earnings expectations. Reported EPS is $0.25, expectations were $0.17.
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q4 2024 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q4 2024 Earnings Call Transcript March 11, 2025Nature's Sunshine Products, Inc. misses on earnings expectations.
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q3 2024 Earnings Call Transcript
Nature's Sunshine Products, Inc.
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q1 2024 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q1 2024 Earnings Call Transcript May 7, 2024 Nature's Sunshine Products, Inc. misses on earnings expectations.